Your search returned 464 results.

Results
	361.	Oritavancin exhibits dual mode of action to inhibit cell-wall biosynthesis in Staphylococcus aureus. [electronic resource] by Kim, Sung Joon Cegelski, Lynette Stueber, Dirk Singh, Manmilan Dietrich, Evelyne Tanaka, Kelly S E Parr, Thomas R Far, Adel Rafai Schaefer, Jacob Producer: 20080324 In: Journal of molecular biology vol. 377 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	362.	In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates. [electronic resource] by Mendes, Rodrigo E Moet, Gary J Janechek, Mike J Jones, Ronald N Producer: 20100914 In: Antimicrobial agents and chemotherapy vol. 54 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	363.	Use of Oritavancin (Novel New Lipoglycopeptide) in the Treatment of Prosthetic Joint Infections (PJI): A Possible Alternative Novel Approach to a Difficult Problem. [electronic resource] by Antony, Suresh J Cooper, Leigh G Producer: 20180501 In: Infectious disorders drug targets vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	364.	Treatment of Multidrug-Resistant Vancomycin-Resistant Enterococcus faecium Hardware-Associated Vertebral Osteomyelitis with Oritavancin plus Ampicillin. [electronic resource] by Dahesh, Samira Wong, Brian Nizet, Victor Sakoulas, George Tran, Truc T Aitken, Samuel L Producer: 20200513 In: Antimicrobial agents and chemotherapy vol. 63 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	365.	Studies on the mechanism of telavancin decreased susceptibility in a laboratory-derived mutant. [electronic resource] by Song, Yang Lunde, Christopher S Benton, Bret M Wilkinson, Brian J Producer: 20140206 In: Microbial drug resistance (Larchmont, N.Y.) vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	366.	Surface mediated cooperative interactions of drugs enhance mechanical forces for antibiotic action. [electronic resource] by Ndieyira, Joseph W Bailey, Joe Patil, Samadhan B Vögtli, Manuel Cooper, Matthew A Abell, Chris McKendry, Rachel A Aeppli, Gabriel Producer: 20181025 In: Scientific reports vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	367.	Evaluation of Antibiotics Active against Methicillin-Resistant Staphylococcus aureus Based on Activity in an Established Biofilm. [electronic resource] by Meeker, Daniel G Beenken, Karen E Mills, Weston B Loughran, Allister J Spencer, Horace J Lynn, William B Smeltzer, Mark S Producer: 20170704 In: Antimicrobial agents and chemotherapy vol. 60 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	368.	Pharmacodynamic evaluation of a new glycopeptide, LY333328, and in vitro activity against Staphylococcus aureus and Enterococcus faecium. [electronic resource] by Mercier, R C Houlihan, H H Rybak, M J Producer: 19970731 In: Antimicrobial agents and chemotherapy vol. 41 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	369.	Telavancin versus standard therapy for treatment of complicated skin and skin structure infections caused by gram-positive bacteria: FAST 2 study. [electronic resource] by Stryjewski, Martin E Chu, Vivian H O'Riordan, William D Warren, Brian L Dunbar, Lala M Young, David M Vallée, Marc Fowler, Vance G Morganroth, Joel Barriere, Steven L Kitt, Michael M Corey, G Ralph Producer: 20060427 In: Antimicrobial agents and chemotherapy vol. 50 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	370.	Telavancin disrupts the functional integrity of the bacterial membrane through targeted interaction with the cell wall precursor lipid II. [electronic resource] by Lunde, Christopher S Hartouni, Stephanie R Janc, James W Mammen, Mathai Humphrey, Patrick P Benton, Bret M Producer: 20091019 In: Antimicrobial agents and chemotherapy vol. 53 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	371.	Comparative surveillance study of telavancin activity against recently collected gram-positive clinical isolates from across the United States. [electronic resource] by Draghi, Deborah C Benton, Bret M Krause, Kevin M Thornsberry, Clyde Pillar, Chris Sahm, Daniel F Producer: 20080915 In: Antimicrobial agents and chemotherapy vol. 52 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	372.	Telavancin: mechanisms of action, in vitro activity, and mechanisms of resistance. [electronic resource] by Karlowsky, James A Nichol, Kim Zhanel, George G Producer: 20160609 In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 61 Suppl 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	373.	Efficacy of oritavancin alone and in combination against vancomycin-susceptible and -resistant enterococci in an in-vivo Galleria mellonella survival model. [electronic resource] by Meyer, Kevin A Deraedt, Matthew F Harrington, Amanda T Danziger, Larry H Wenzler, Eric Producer: 20191203 In: International journal of antimicrobial agents vol. 54 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	374.	Activity of LY333328 in experimental meningitis caused by a Streptococcus pneumoniae strain susceptible to penicillin. [electronic resource] by Gerber, J Smirnov, A Wellmer, A Ragheb, J Prange, J Schütz, E Wettich, K Kalich, S Nau, R Producer: 20011004 In: Antimicrobial agents and chemotherapy vol. 45 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	375.	New lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancin. [electronic resource] by Zhanel, George G Calic, Divna Schweizer, Frank Zelenitsky, Sheryl Adam, Heather Lagacé-Wiens, Philippe R S Rubinstein, Ethan Gin, Alfred S Hoban, Daryl J Karlowsky, James A Producer: 20100716 In: Drugs vol. 70 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	376.	Baseline activity of telavancin against Gram-positive clinical isolates responsible for documented infections in U.S. hospitals (2011-2012) as determined by the revised susceptibility testing method. [electronic resource] by Mendes, Rodrigo E Farrell, David J Sader, Helio S Flamm, Robert K Jones, Ronald N Producer: 20150824 In: Antimicrobial agents and chemotherapy vol. 59 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	377.	Use of Oritavancin in Moderate-to-Severe ABSSSI Patients Requiring IV Antibiotics: A U.S. Payer Budget Impact Analysis. [electronic resource] by Jensen, Ivar S Wu, Elizabeth Fan, Weihong Lodise, Thomas P Nicolau, David P Dufour, Scott Cyr, Philip L Sulham, Katherine A Producer: 20170428 In: Journal of managed care & specialty pharmacy vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	378.	In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe. [electronic resource] by Jansen, W T M Verel, A Verhoef, J Milatovic, D Producer: 20080108 In: Antimicrobial agents and chemotherapy vol. 51 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	379.	Compatibility and stability of telavancin and vancomycin in heparin or sodium citrate lock solutions. [electronic resource] by LaPlante, Kerry L Woodmansee, Suzanne Mermel, Leonard A Producer: 20121204 In: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists vol. 69 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	380.	Pharmacodynamics of telavancin studied in an in vitro pharmacokinetic model of infection. [electronic resource] by MacGowan, Alasdair P Noel, Alan R Tomaselli, Sharon Elliott, Heather C Bowker, Karen E Producer: 20110519 In: Antimicrobial agents and chemotherapy vol. 55 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 464 results.